Lemaitre Vascular (LMAT) Shares Outstanding (Weighted Average) (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $22.8 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 1.02% year-over-year to $22.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.8 million (up 1.02% YoY) and the FY2025 annual result came in at $22.6 million, up 0.83% from the prior year.
• Shares Outstanding (Weighted Average) rose to $22.8 million in Q1 2026 per LMAT's latest filing, from $22.6 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $22.8 million in Q1 2026 and bottomed at $21.9 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $22.4 million (2024), against an average of $22.3 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) advanced 6.76%; it then advanced 0.6% in 2025.
• Tracing LMAT's Shares Outstanding (Weighted Average) over 5 years: stood at $22.0 million in 2022, then grew by 1.1% to $22.2 million in 2023, then climbed by 1.06% to $22.5 million in 2024, then gained by 0.83% to $22.6 million in 2025, then rose by 0.72% to $22.8 million in 2026.
• Per Business Quant, the three latest LMAT Shares Outstanding (Weighted Average) figures stand at $22.8 million (Q1 2026), $22.6 million (Q4 2025), and $22.7 million (Q3 2025).

Peer Comparison